The use of adenoviral vectors in gene therapy and vaccine approaches
Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...
Main Authors: | Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Sociedade Brasileira de Genética
2022-10-01
|
סדרה: | Genetics and Molecular Biology |
נושאים: | |
גישה מקוונת: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en |
פריטים דומים
-
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
מאת: Jingao Guo, et al.
יצא לאור: (2018-07-01) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
מאת: Lynda Coughlan
יצא לאור: (2020-05-01) -
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
מאת: Luca Scarsella, et al.
יצא לאור: (2024-02-01) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
מאת: Rodrigo Esaki Tamura, et al.
יצא לאור: (2018-08-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
מאת: L. V. Cherenova, et al.
יצא לאור: (2017-08-01)